The DePuy Synthes Attune Leg System was initially introduced this year 2010 as a tool that could improve patient results for total arthroplasty to revive the function of the bones in the leg.
DePuy Synthes, a subsidiary of Johnson & Johnson, promoted these devices as having “patented solutions” that significantly improve range and action and offer patients “the self-assurance of a well balanced knee replacing.” However, a large number of reviews have been submitted with the U.S. Food and Medication Administration (FDA) describing early failures of the Attune(C) Leg System.
A large number of patients have been implanted with the Attune(C) Leg System, a lot of whom have observed premature failing that triggered symptoms such as:
- Instability and loosening
- Bloating in the knee
- Bone or muscle damage
- Reduced range and motion
- Continuous pain
Oftentimes, the one effective solution for patients who experience a faulty Attune Leg System is to endure a revision surgery to eliminate these devices and replace it. You can get information about the depuy attune knee lawsuit via http://www.depuykneelawsuit.com/depuy-knee-lawsuits.aspx
Study Sees DePuy Leg Systems are inclined to Failure
In the 2017 study released in the Journal of Leg Surgery, nine orthopedic doctors claim that they had learned a “higher rate of debonding of tibial implant-cement user interface” in the DePuy leg substitution system, which probably induced significant instability in patients.